根据 位华尔街分析师的预测,RBC Life Sciences Inc 的收入预期范围从 $ 到 $
RBC Life Sciences Inc 的盈利质量评分是多少?
RBC Life Sciences Inc 的盈利质量评分为 B+/46.023922。该评分基于盈利能力、增长、现金生成与资本分配以及杠杆四个维度。
RBC Life Sciences Inc 何时发布财报?
RBC Life Sciences Inc 的下一份财报预计在 发布
RBC Life Sciences Inc 的预期收益是多少?
根据华尔街分析师的预测,RBC Life Sciences Inc 的预期收益为 $
RBC Life Sciences Inc 是否超出收益预期?
RBC Life Sciences Inc 最近的收益为 $, 预期。
关键数据
前收盘价
$0.0007
开盘价
$0.0002
当日区间
$0.0002 - $0.0007
52周范围
$0.0001 - $0.0007
交易量
2.1K
平均成交量
5
股息收益率
--
每股收益(TTM)
-0.25
市值
$1.5K
什么是 RBCL?
RBC Life Sciences, Inc. engages in the marketing and distribution of nutritional supplements and personal care products. The company is headquartered in Irving, Texas. The firm's segments include Nutritional Products and Medical Products. Its Nutritional Products segment distributes products in over three categories: wellness products, fitness products and personal care products. Its Medical Products segment distributes wound care products. Nutritional Products are marketed under the RBC Life brand name. As of September 30, 2015, its Nutritional Products segment manufactured and distributed a line of over 100 nutritional supplements and personal care products, including herbs, vitamins and minerals, as well as natural skin, hair and body care products. As of September 30, 2015, it marketed a line of over 35 wound care products under the MPM Medical brand name through a subsidiary operating primarily in the United States.